Top learning and CPD articles of 2016 Natasha Leeson provides the most popular learning and CPD articles published in The Pharmaceutical Journal and Clinical Pharmacist in 2016.…
Fruits and vegetables lower blood pressure and slash medication costs for kidney disease patients The cost of antihypertensive drugs nearly halved when researchers assigned patients to eat alkali-inducing fruit and vegetables.…
Lowered blood pressure target for chronic kidney disease may prevent premature death A blood pressure target below 140/90mmHg for patients with chronic kidney disease who are at risk of cardiovascular disease is safe and may prevent premature death, a study has found.…
Older patients may benefit from slightly higher blood pressure targets High systolic blood pressure is linked to poorer outcomes among patients with chronic kidney disease, but this association is weaker among older patients, a study shows.…
Proton-pump inhibitors increase risk of kidney damage Use of proton-pump inhibitors increases the risk of long-term kidney damage, a study shows. …
Study shows value of community pharmacists screening patients for chronic kidney disease Community pharmacists can play a key role in diagnosing patients with unrecognised chronic kidney disease, suggests new research published in the Canadian Pharmacists Journal.…
PPI use increases risk of chronic kidney disease by as much as 50% Proton pump inhibitors — used to inhibit gastric acid secretion — are associated with a 20–50% increase in the risk of developing chronic kidney disease, according to new research.…
Chronic Kidney Disease – Mineral and Bone Disorder: pathophysiology and treatment How the pathophysiological mechanisms behind development of Chronic Kidney Disease - Mineral and Bone Disorder can be managed, using appropriate therapeutic interventions to prevent complications.…
Ibuprofen could provide alternative to antibiotics for uncomplicated UTIs Two-thirds of women found ibuprofen to be sufficient treatment for uncomplicated infection.…
Absolute levels of risk are needed to make informed decisions for patientsRenal adverse effects of proton pump inhibitors (PPIs) were described in your research briefing ‘Proton pump inhibitors linked with chronic kidney disease’ ( Clinical Pharmacist 2015;7:217). Simply telling us that there was a 10% or 50% increase among …
